These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1369994)

  • 1. Expression in yeast of amino-terminal peptide fusions to hepatitis B core antigen and their immunological properties.
    Beesley KM; Francis MJ; Clarke BE; Beesley JE; Dopping-Hepenstal PJ; Clare JJ; Brown F; Romanos MA
    Biotechnology (N Y); 1990 Jul; 8(7):644-9. PubMed ID: 1369994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Presentation and immunogenicity of viral epitopes on the surface of hybrid hepatitis B virus core particles produced in bacteria.
    Clarke BE; Brown AL; Grace KG; Hastings GZ; Brown F; Rowlands DJ; Francis MJ
    J Gen Virol; 1990 May; 71 ( Pt 5)():1109-17. PubMed ID: 1693163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foreign epitopes in immunodominant regions of hepatitis B core particles are highly immunogenic and conformationally restricted.
    Brown AL; Francis MJ; Hastings GZ; Parry NR; Barnett PV; Rowlands DJ; Clarke BE
    Vaccine; 1991 Aug; 9(8):595-601. PubMed ID: 1722937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modified-live infectious bovine rhinotracheitis virus vaccine expressing monomer and dimer forms of foot-and-mouth disease capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi RD; Little SP; Gale C
    Arch Virol; 1991; 120(1-2):1-17. PubMed ID: 1718244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New chimaeric hepatitis B virus core particles carrying hantavirus (serotype Puumala) epitopes: immunogenicity and protection against virus challenge.
    Ulrich R; Koletzki D; Lachmann S; Lundkvist A; Zankl A; Kazaks A; Kurth A; Gelderblom HR; Borisova G; Meisel H; Krüger DH
    J Biotechnol; 1999 Aug; 73(2-3):141-53. PubMed ID: 10486924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein.
    Clarke BE; Newton SE; Carroll AR; Francis MJ; Appleyard G; Syred AD; Highfield PE; Rowlands DJ; Brown F
    Nature; 1987 Nov 26-Dec 2; 330(6146):381-4. PubMed ID: 2446137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of the epitope of the foot-and-mouth disease virus fused with a hepatitis B core protein as expressed in transgenic tobacco.
    Huang Y; Liang W; Wang Y; Zhou Z; Pan A; Yang X; Huang C; Chen J; Zhang D
    Viral Immunol; 2005; 18(4):668-77. PubMed ID: 16359233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus core and e antigen: immune recognition and use as a vaccine carrier moiety.
    Schödel F; Peterson D; Milich D
    Intervirology; 1996; 39(1-2):104-10. PubMed ID: 8957676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes.
    Schödel F; Peterson D; Hughes J; Wirtz R; Milich D
    J Biotechnol; 1996 Jan; 44(1-3):91-6. PubMed ID: 8717391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
    Shiau AL; Murray K
    J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a human cytomegalovirus gp58 antigenic domain fused to the hepatitis B virus nucleocapsid protein.
    Tarar MR; Emery VC; Harrison TJ
    FEMS Immunol Med Microbiol; 1996 Dec; 16(3-4):183-92. PubMed ID: 9116635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principal neutralizing domain of HIV-1 is highly immunogenic when expressed on the surface of hepatitis B core particles.
    von Brunn A; Brand M; Reichhuber C; Morys-Wortmann C; Deinhardt F; Schödel F
    Vaccine; 1993; 11(8):817-24. PubMed ID: 7689283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus.
    Broekhuijsen MP; Blom T; van Rijn J; Pouwels PH; Klasen EA; Fasbender MJ; Enger-Valk BE
    Gene; 1986; 49(2):189-97. PubMed ID: 2436976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bacterial synthesis of immunogenic epitopes of foot-and-mouth disease virus fused either to human necrosis factor or to hepatitis B core antigen].
    Nekrasova OV; Boĭchenko VE; Boldyreva EF; Borisova GP; Pumpen P; Perevozchikova NA; Korobko VG
    Bioorg Khim; 1997 Feb; 23(2):118-26. PubMed ID: 9157845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological properties of hepatitis B core antigen fusion proteins.
    Francis MJ; Hastings GZ; Brown AL; Grace KG; Rowlands DJ; Brown F; Clarke BE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2545-9. PubMed ID: 2320575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Core particles of hepatitis B virus as carrier for foreign epitopes.
    Ulrich R; Nassal M; Meisel H; Krüger DH
    Adv Virus Res; 1998; 50():141-82. PubMed ID: 9520999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice.
    Tindle RW; Herd K; Londoño P; Fernando GJ; Chatfield SN; Malcolm K; Dougan G
    Virology; 1994 May; 200(2):547-57. PubMed ID: 7513919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus core-preS2 particles expressed by recombinant vaccinia virus.
    Nemecková S; Sroller V; Kunke D; Krystofová J; Kutinová L
    Acta Virol; 1996; 40(5-6):273-9. PubMed ID: 9171455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced immunogenicity of modified hepatitis B virus core particle fused with multiepitopes of foot-and-mouth disease virus.
    Zhang YL; Guo YJ; Wang KY; Lu K; Li K; Zhu Y; Sun SH
    Scand J Immunol; 2007 Apr; 65(4):320-8. PubMed ID: 17386022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.